Page last updated: 2024-10-29

irsogladine and Gastroesophageal Reflux

irsogladine has been researched along with Gastroesophageal Reflux in 1 studies

irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt

Gastroesophageal Reflux: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.

Research Excerpts

ExcerptRelevanceReference
"The addition of IM to rabeprazole significantly improves gastroesophageal reflux disease symptoms and the quality of the lives of patients with NERD grade N."5.20Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study. ( Igarashi, M; Imai, J; Koike, J; Masui, A; Matsushima, M; Mine, T; Nakamura, J; Suzuki, T; Tsuda, S; Tsukune, Y; Uchida, T; Yuhara, H, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, T1
Matsushima, M1
Masui, A1
Tsuda, S1
Imai, J1
Nakamura, J1
Tsukune, Y1
Uchida, T1
Yuhara, H1
Igarashi, M1
Koike, J1
Mine, T1

Trials

1 trial available for irsogladine and Gastroesophageal Reflux

ArticleYear
Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
    World journal of gastroenterology, 2015, Apr-28, Volume: 21, Issue:16

    Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Gastroesopha

2015